Midterml Exam:l NRl 567/l NR567l (2026/l
2027)l Advancedl Pharmacologyl forl thel
AGACNPl Reviewl |l Questionsl &l Answersl
|l Gradel A|l 100%l Correctl (Verifiedl
Solutions)-Chamberlain
QUESTION
Whatl ACEI'sl decreasel shortl terml mortalityl inl alll patientsl andl longl terml mortalityl inl
patientsl withl reducedl LV?
Answer:
captoprill andl lisinopril
QUESTION
Whatl isl dosagel ofl statinl afterl STEMI?
Answer:
highl intensityl statinl ASAP
Atorvastatinl 40-80mgl
Rosuvastatinl 20mg
QUESTION
Whatl shouldl alll patientsl undergoingl PCIl recieve?
Answer:
anticoagulantl (heparin,l bivalirudin),l combinedl withl antiplateletl (asal plusl eitherl plavix,l
ticagrelorl orl prasurgel)l andl perhapsl glycoproteinl IIb/IIIal inhibitor
, QUESTION
Whatl arel examplesl ofl glycoproteinl IIb/IIIal inhibitors?
Answer:
Abciximabl (ReoPro),l Eptifibatidel (Integrilin),l andl Tirofibanl (Aggrastat)
QUESTION
Al patientl isl havingl al STEMIl andl isl receivingl fibrinolyticl therapy.l Thel patientl needsl
heparinl -l whenl dol youl startl andl howl longl doesl itl stayl on?
Answer:
Startl beforel thel fibrinolyticl andl continuel forl 48-72l hoursl after
QUESTION
Whatl dosel ofl plavixl isl recommendedl forl ACS?
Answer:
Plavisl 300mgl oncel followedl byl 75mg/day
QUESTION
Isl antiplateletl therapyl withl aspirinl recommended?
Answer:
Clopidogrell shouldl alwaysl bel combinedl withl aspirinl (75-325mgl oncel daily)
QUESTION
Whatl isl thel MOAl ofl fibrinolytics?
Alteplasel /l tenecteplasel /l reteplase
Answer:
promotel conversionl ofl plasminogenl tol plasmin,l whichl degradesl fibrinl inl clots
2027)l Advancedl Pharmacologyl forl thel
AGACNPl Reviewl |l Questionsl &l Answersl
|l Gradel A|l 100%l Correctl (Verifiedl
Solutions)-Chamberlain
QUESTION
Whatl ACEI'sl decreasel shortl terml mortalityl inl alll patientsl andl longl terml mortalityl inl
patientsl withl reducedl LV?
Answer:
captoprill andl lisinopril
QUESTION
Whatl isl dosagel ofl statinl afterl STEMI?
Answer:
highl intensityl statinl ASAP
Atorvastatinl 40-80mgl
Rosuvastatinl 20mg
QUESTION
Whatl shouldl alll patientsl undergoingl PCIl recieve?
Answer:
anticoagulantl (heparin,l bivalirudin),l combinedl withl antiplateletl (asal plusl eitherl plavix,l
ticagrelorl orl prasurgel)l andl perhapsl glycoproteinl IIb/IIIal inhibitor
, QUESTION
Whatl arel examplesl ofl glycoproteinl IIb/IIIal inhibitors?
Answer:
Abciximabl (ReoPro),l Eptifibatidel (Integrilin),l andl Tirofibanl (Aggrastat)
QUESTION
Al patientl isl havingl al STEMIl andl isl receivingl fibrinolyticl therapy.l Thel patientl needsl
heparinl -l whenl dol youl startl andl howl longl doesl itl stayl on?
Answer:
Startl beforel thel fibrinolyticl andl continuel forl 48-72l hoursl after
QUESTION
Whatl dosel ofl plavixl isl recommendedl forl ACS?
Answer:
Plavisl 300mgl oncel followedl byl 75mg/day
QUESTION
Isl antiplateletl therapyl withl aspirinl recommended?
Answer:
Clopidogrell shouldl alwaysl bel combinedl withl aspirinl (75-325mgl oncel daily)
QUESTION
Whatl isl thel MOAl ofl fibrinolytics?
Alteplasel /l tenecteplasel /l reteplase
Answer:
promotel conversionl ofl plasminogenl tol plasmin,l whichl degradesl fibrinl inl clots